Crossmark

Groundbreaking Benzofused Hybrid Drug: Light-Responsive Reversible Absorption and Release in Hydrogel for Treating Kashin–Beck Disease

Published Online: 2024-10-29

Published Print: 2024-09

Authors

Feng, L.

Yang, J.

Wang, J.

Meng, S.

Yu, H.

Han, L.

Zhong, W.
License Information

Text and Data Mining valid from 2024-09-01

Version of Record valid from 2024-09-01
More Information

Article History

Received: 22 June 2024

Revised: 15 August 2024

Accepted: 10 September 2024

First Online: 29 October 2024

CONFLICT OF INTEREST

: The authors declare no conflict of interest.

Document is current